Preoperative CareAntineoplastic Combined Chemotherapy ProtocolsNeoadjuvant TherapyCombined Modality TherapyChemotherapy, AdjuvantTreatment OutcomeRadiation InjuriesCisplatinDoxorubicinNeoplasm StagingRadiotherapyRadiotherapy DosageRadiation DosageBreast NeoplasmsDisease-Free SurvivalWilms TumorCyclophosphamideOsteosarcomaFluorouracilRadiation, IonizingNeoplasm Recurrence, LocalSurvival AnalysisPrognosisDose-Response Relationship, RadiationAntineoplastic AgentsHepatoblastomaSurvival RateRadiotherapy, ConformalBone NeoplasmsRadiotherapy, Intensity-ModulatedPreoperative PeriodRadiotherapy, AdjuvantRetrospective StudiesAdenocarcinomaRadiation ToleranceEsophageal NeoplasmsMastectomy, SegmentalDose FractionationFollow-Up StudiesRadiation OncologyHepatic InsufficiencyHepatectomyDrug Administration ScheduleLiver NeoplasmsLung NeoplasmsRadiotherapy Planning, Computer-AssistedLymphatic MetastasisTime FactorsTaxoidsPaclitaxelCarcinoma, Squamous CellRadiationBrachytherapyOrganoplatinum CompoundsSarcomaMethotrexateIfosfamidePeplomycinKaplan-Meier EstimateEpirubicinMitomycinProspective StudiesMastectomyNeoplasm, ResidualRadiation ProtectionRadiation PneumonitisBleomycinBrain NeoplasmsRadiosurgeryOxonic AcidStomach NeoplasmsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsCranial IrradiationRadiation MonitoringPredictive Value of TestsTegafurEsophagectomyTomography, X-Ray ComputedRadiotherapy, Computer-AssistedRadiometryHead and Neck NeoplasmsCamptothecinRectal NeoplasmsTumor Markers, BiologicalRadiation-Sensitizing AgentsEsophagogastric JunctionNeoplasmsRadiotherapy, Image-GuidedNeoplasms, Radiation-InducedChemoradiotherapyKidney NeoplasmsParticle AcceleratorsProportional Hazards ModelsRadiotherapy, High-EnergyEtoposideLeucovorinBiopsy, NeedleAntibodies, Monoclonal, HumanizedExtremities